Sidmap Provides Metabolic Phenotyping Services
News Aug 17, 2005
Sidmap has announced the signing of agreements with investigators and researchers at Harvard Medical School's Joslin Diabetes Center and the University of Utah to use its isotope-based metabolic phenotyping services.
Mary-Elizabeth Patti, M.D., of the Joslin Diabetes Center at Harvard Medical School, engaged Sidmap to conduct a series of profiles to determine the metabolic perturbations of a diabetes model currently under investigation.
"The early information provided by Sidmap has been extremely revealing. The results were provided promptly and I expect to continue working with Dr. Boros and his team in the future," Dr. Patti said.
Don McClain, Ph.D., of the University of Utah, is using Sidmap's metabolic phenotyping services to evaluate an in vivo model for type II diabetes.
"The work Drs. Boros and Lee are doing is extremely exciting and we are expecting some unique insights from the metabolic profiles Sidmap is providing," said Dr. McClain.
"We are extremely pleased that these prestigious academic institutions have chosen SIDMAP as their metabolic solutions provider," said David Manheim, Sidmap's Vice President of Operations and General Counsel.
He adds, "We continue to work with pharmaceutical and biotech companies as well as academic institutions which have embraced our technology as a useful tool to enhance their research and drug development efforts. Our pipeline is robust and should continue to grow as more people learn about the dynamic biochemical information we provide."
Rapid and Cost-Effective Instrument that Measures Molecular DynamicsNews
By combining mass spectrometry and thermal desorption, researchers honed a new method to measure excitation and relaxation rates of uracil, the building block of RNA.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Getting to Know the Microbes that Drive Climate ChangeNews
A new understanding of the microbes and viruses in the thawing permafrost in Sweden may help scientists better predict the pace of climate change.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019